JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1

Despite significant improvements in five-year survival rates due to early diagnosis and combination therapy, triple-negative breast cancer (TNBC) treatment remains a major challenge. Finding new and effective targets for diagnosis and drug therapy is urgent for TNBC patients. Jagged-1 (JAG1), one of...

Full description

Bibliographic Details
Main Authors: Junping Liu, Yutong Shi, Minmin Wu, Fengmei Zhang, Mengqi Xu, Zhiqiang He, Min Tang
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2023-09-01
Series:Genes and Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352304222002021
_version_ 1797782705138565120
author Junping Liu
Yutong Shi
Minmin Wu
Fengmei Zhang
Mengqi Xu
Zhiqiang He
Min Tang
author_facet Junping Liu
Yutong Shi
Minmin Wu
Fengmei Zhang
Mengqi Xu
Zhiqiang He
Min Tang
author_sort Junping Liu
collection DOAJ
description Despite significant improvements in five-year survival rates due to early diagnosis and combination therapy, triple-negative breast cancer (TNBC) treatment remains a major challenge. Finding new and effective targets for diagnosis and drug therapy is urgent for TNBC patients. Jagged-1 (JAG1), one of the canonical ligands of the Notch signaling pathway, is involved in vascular budding and is a poor prognostic factor of TNBC. In this study, combined with quantitative real-time PCR, database analysis, animal experiments, and other means, JAG1 was confirmed to be related to the poor prognosis of TNBC patients. JAG1 was highly expressed in MDA-MB-231 Bone (231B) cells, with stronger invasion and metastasis ability than MDA-MB-231 (231) cells. Treatment of human vascular endothelial cells (HUVEC) with TNBC conditioned medium showed that TNBC JAG1 promoted the angiogenesis of HUVEC. Next, we detected the exosomes extracted from TNBC conditioned medium and found that JAG1 promoted the exosome secretion from 231 cells via ALIX-RAB11A/RAB35. In addition, we also found that the exosomes from JAG1 overexpressed TNBC cells contained more long non-coding RNA (lncRNA) MALAT1, and MALAT1 promoted angiogenesis of HUVEC by targeting miR-140-5p. Finally, the angiogenesis-promoting effect of JAG1 in TNBC was further investigated by matrix gel assay. In conclusion, we reveal that JAG1 has a pro-invasion effect on TNBC and is involved in microenvironment angiogenesis by promoting exosome secretion and the MALAT1-miR-140-5p-JAG1/VEGFA pathway.
first_indexed 2024-03-13T00:14:44Z
format Article
id doaj.art-abc393386b16458fab4962b2adc11028
institution Directory Open Access Journal
issn 2352-3042
language English
last_indexed 2024-03-13T00:14:44Z
publishDate 2023-09-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Genes and Diseases
spelling doaj.art-abc393386b16458fab4962b2adc110282023-07-12T04:19:36ZengKeAi Communications Co., Ltd.Genes and Diseases2352-30422023-09-0110521672178JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1Junping Liu0Yutong Shi1Minmin Wu2Fengmei Zhang3Mengqi Xu4Zhiqiang He5Min Tang6Key Laboratory of Laboratory Medical Diagnostics Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, ChinaKey Laboratory of Laboratory Medical Diagnostics Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, ChinaKey Laboratory of Laboratory Medical Diagnostics Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, ChinaKey Laboratory of Laboratory Medical Diagnostics Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, ChinaKey Laboratory of Laboratory Medical Diagnostics Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, ChinaKey Laboratory of Laboratory Medical Diagnostics Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, ChinaCorresponding author.; Key Laboratory of Laboratory Medical Diagnostics Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, ChinaDespite significant improvements in five-year survival rates due to early diagnosis and combination therapy, triple-negative breast cancer (TNBC) treatment remains a major challenge. Finding new and effective targets for diagnosis and drug therapy is urgent for TNBC patients. Jagged-1 (JAG1), one of the canonical ligands of the Notch signaling pathway, is involved in vascular budding and is a poor prognostic factor of TNBC. In this study, combined with quantitative real-time PCR, database analysis, animal experiments, and other means, JAG1 was confirmed to be related to the poor prognosis of TNBC patients. JAG1 was highly expressed in MDA-MB-231 Bone (231B) cells, with stronger invasion and metastasis ability than MDA-MB-231 (231) cells. Treatment of human vascular endothelial cells (HUVEC) with TNBC conditioned medium showed that TNBC JAG1 promoted the angiogenesis of HUVEC. Next, we detected the exosomes extracted from TNBC conditioned medium and found that JAG1 promoted the exosome secretion from 231 cells via ALIX-RAB11A/RAB35. In addition, we also found that the exosomes from JAG1 overexpressed TNBC cells contained more long non-coding RNA (lncRNA) MALAT1, and MALAT1 promoted angiogenesis of HUVEC by targeting miR-140-5p. Finally, the angiogenesis-promoting effect of JAG1 in TNBC was further investigated by matrix gel assay. In conclusion, we reveal that JAG1 has a pro-invasion effect on TNBC and is involved in microenvironment angiogenesis by promoting exosome secretion and the MALAT1-miR-140-5p-JAG1/VEGFA pathway.http://www.sciencedirect.com/science/article/pii/S2352304222002021AngiogenesisExosomeJAG1lncRNAMALAT1Triple-negative breast cancer
spellingShingle Junping Liu
Yutong Shi
Minmin Wu
Fengmei Zhang
Mengqi Xu
Zhiqiang He
Min Tang
JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1
Genes and Diseases
Angiogenesis
Exosome
JAG1
lncRNAMALAT1
Triple-negative breast cancer
title JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1
title_full JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1
title_fullStr JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1
title_full_unstemmed JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1
title_short JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1
title_sort jag1 enhances angiogenesis in triple negative breast cancer through promoting the secretion of exosomal lncrna malat1
topic Angiogenesis
Exosome
JAG1
lncRNAMALAT1
Triple-negative breast cancer
url http://www.sciencedirect.com/science/article/pii/S2352304222002021
work_keys_str_mv AT junpingliu jag1enhancesangiogenesisintriplenegativebreastcancerthroughpromotingthesecretionofexosomallncrnamalat1
AT yutongshi jag1enhancesangiogenesisintriplenegativebreastcancerthroughpromotingthesecretionofexosomallncrnamalat1
AT minminwu jag1enhancesangiogenesisintriplenegativebreastcancerthroughpromotingthesecretionofexosomallncrnamalat1
AT fengmeizhang jag1enhancesangiogenesisintriplenegativebreastcancerthroughpromotingthesecretionofexosomallncrnamalat1
AT mengqixu jag1enhancesangiogenesisintriplenegativebreastcancerthroughpromotingthesecretionofexosomallncrnamalat1
AT zhiqianghe jag1enhancesangiogenesisintriplenegativebreastcancerthroughpromotingthesecretionofexosomallncrnamalat1
AT mintang jag1enhancesangiogenesisintriplenegativebreastcancerthroughpromotingthesecretionofexosomallncrnamalat1